L-DOPA-induced dyskinesia is associated with regional increase of striatal dynorphin peptides as elucidated by imaging mass spectrometry.
about
Imaging mass spectrometry in neuroscience.Imaging mass spectrometry reveals elevated nigral levels of dynorphin neuropeptides in L-DOPA-induced dyskinesia in rat model of Parkinson's diseaseAnalysis of tissue specimens by matrix-assisted laser desorption/ionization imaging mass spectrometry in biological and clinical research.Top-down proteomics with mass spectrometry imaging: a pilot study towards discovery of biomarkers for neurodevelopmental disordersLithium Accumulates in Neurogenic Brain Regions as Revealed by High Resolution Ion ImagingMass spectrometry imaging, an emerging technology in neuropsychopharmacology.Matrix-assisted laser desorption ionization imaging mass spectrometry: in situ molecular mapping.Quality measures of imaging mass spectrometry aids in revealing long-term striatal protein changes induced by neonatal exposure to the cyanobacterial toxin β-N-methylamino-L-alanine (BMAA)Probing neuropeptide signaling at the organ and cellular domains via imaging mass spectrometry.MALDI imaging mass spectrometry and analysis of endogenous peptides.Spatial elucidation of spinal cord lipid- and metabolite- regulations in amyotrophic lateral sclerosis.Challenges and recent advances in mass spectrometric imaging of neurotransmitters.Mapping of neuropeptides in the crustacean stomatogastric nervous system by imaging mass spectrometry.Matrix-assisted laser desorption ionization-imaging mass spectrometry: a new methodology to study human osteoarthritic cartilage.Approaches for the analysis of low molecular weight compounds with laser desorption/ionization techniques and mass spectrometry.Current peptidomics: applications, purification, identification, quantification, and functional analysisMALDI mass spectrometric imaging meets "omics": recent advances in the fruitful marriage.Proteomics of the Synapse--A Quantitative Approach to Neuronal Plasticity.Defining the Neuropeptidome of the Spiny Lobster Panulirus interruptus Brain Using a Multidimensional Mass Spectrometry-Based Platform.The use of MALDI-MSI in the investigation of psychiatric and neurodegenerative disorders: A review.Reduced Vglut2/Slc17a6 Gene Expression Levels throughout the Mouse Subthalamic Nucleus Cause Cell Loss and Structural Disorganization Followed by Increased Motor Activity and Decreased Sugar ConsumptionMALDI imaging delineates hippocampal glycosphingolipid changes associated with neurotoxin induced proteopathy following neonatal BMAA exposure.Delineating Amyloid Plaque Associated Neuronal Sphingolipids in Transgenic Alzheimer's Disease Mice (tgArcSwe) Using MALDI Imaging Mass Spectrometry.Opioid system in L-DOPA-induced dyskinesia.Neuropeptide imaging in rat spinal cord with MALDI-TOF MS: Method development for the application in pain-related disease studies.Imaging mass spectrometry in drug development and toxicologyAxial levodopa-induced dyskinesias and neuronal activity in the dorsal striatum.New therapeutic strategies targeting D1-type dopamine receptors for neuropsychiatric disease.Physical Exercise Modulates L-DOPA-Regulated Molecular Pathways in the MPTP Mouse Model of Parkinson's Disease.Dual κ-agonist/μ-antagonist opioid receptor modulation reduces levodopa-induced dyskinesia and corrects dysregulated striatal changes in the nonhuman primate model of Parkinson disease.
P2860
Q27024594-E378E177-ED19-41A9-BFB9-C4DF3B738FBDQ27317506-38730CFB-8627-44FD-AB31-8372FBE7CC82Q28396816-14747296-F85F-493B-83B2-3FFCF0E37C22Q28542079-DA18B673-D19D-4D5E-ABCB-9564C128C3B0Q28816923-BE20E971-69EE-4B23-87E4-AE23A6868008Q30422058-79948C9A-F7D0-45AC-97CB-25DF962840DEQ30437243-90D9A44C-E3AB-4CC0-8C40-FF09F07B2040Q30444494-BF96556C-F84D-4B3A-8A41-6BBA69F351F7Q30450144-75A1CFF5-CFCE-4248-B31A-45BF22A49146Q31134599-6690BBE2-8279-41BA-B7FA-D383675C8871Q33741671-816303C4-208E-48A7-92BD-35976906F8FFQ34157765-F99DB979-296F-49CA-969D-1472407660F4Q34495004-9723DC2F-0A20-4707-A04A-64DFB71418C3Q34529048-2210AE99-8A97-48C4-97A6-39A1D6463B19Q35063365-21164B3D-99D1-40F0-8A05-97BC6B360D8EQ35212347-D760D924-7A9C-4C8C-B2CE-ADE398956634Q35687880-3A1B3186-93C5-4265-AAFB-A8AC29101786Q35755401-5DDB7C7F-DE94-43DA-B62E-B61C9926CA0EQ35781949-B19C9BF5-8B5D-4DA2-8F4B-3E0409262B05Q36052708-A78C584F-B317-4D4D-9A11-ED5297074FEEQ36152395-F874ACC4-A1EB-450C-9D19-7C6CBB762944Q36221110-CED3F462-C6A4-43C7-8127-9FFF59D7AD44Q36226843-99BC8E3C-B87C-45D5-B786-4519E7FA1DB1Q37589209-F8BE55C3-B3F3-4FF4-B354-4D9795755F27Q38665681-00BD4796-E2A0-4D01-BFA5-6A7D9B018F31Q39033781-7AAE6620-B6BD-4503-8369-2704AEEE3451Q39107780-A9B96056-F388-43AA-8110-27073BF00CA0Q39172080-03C7D739-93FA-4418-9752-17E161311448Q42696309-B3D5ACF8-04BF-46CA-8F95-C6F5C33384F3Q44350349-198F1573-3264-420E-8532-EF84C95E9764
P2860
L-DOPA-induced dyskinesia is associated with regional increase of striatal dynorphin peptides as elucidated by imaging mass spectrometry.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
L-DOPA-induced dyskinesia is a ...... by imaging mass spectrometry.
@ast
L-DOPA-induced dyskinesia is a ...... by imaging mass spectrometry.
@en
type
label
L-DOPA-induced dyskinesia is a ...... by imaging mass spectrometry.
@ast
L-DOPA-induced dyskinesia is a ...... by imaging mass spectrometry.
@en
prefLabel
L-DOPA-induced dyskinesia is a ...... by imaging mass spectrometry.
@ast
L-DOPA-induced dyskinesia is a ...... by imaging mass spectrometry.
@en
P2093
P2860
P921
P356
P1476
L-DOPA-induced dyskinesia is a ...... d by imaging mass spectrometry
@en
P2093
Anna Ljungdahl
Jörg Hanrieder
Maria Fälth
Sofie Eriksson Mammo
P2860
P304
M111.009308
P356
10.1074/MCP.M111.009308
P577
2011-07-06T00:00:00Z